In patients combined with manifestations of 21OHD and 17OHD, corresponding gene tests including CYP21A2, CYP17A1, CYP19A1, and POR are beneficial for establishing molecular diagnosis. This evidence concerns the gene CYP21A2 and classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.